Table 2.
Confounds | 1 | 2 | 3 | 4 | 5 |
---|---|---|---|---|---|
Depressed vs nondepressed (1) | 0.21*** | −0.03 | 0.17** | 0.17** | |
HIV-associated brain involvement history vs none (2) | 0.21*** | −0.16** | −0.01 | 0.02 | |
Non-HIV–associated neurological/psychiatric history vs none (3) | −0.03 | −0.16** | −0.03 | 0.05 | |
Alcohol use disorder within the last 12 months vs none (4) | 0.17** | −0.01 | −0.03 | 0.16** | |
Substance use disorder within the last 12 months vs none (5) | 0.17** | 0.02 | 0.05 | 0.16** |
Point biserial correlations significance: *P < .05; **P < .01 ***P < .001. All variables were coded as dummy 1/0, with 1 representing an event occurrence. A history of HIV brain involvement included cases with past HIV–associated neurocognitive disorders and/or central nervous system (CNS) opportunistic infections (N = 32, 7 with CNS opportunistic infection that had been treated prior to study entry in the sense that those were not currently active). A history of non-HIV neurological or psychiatric condition included (N = 39): 4 cases with mild stroke, 1 case with mild stroke and Substance use disorder within the last 12 months (SUD), 26 cases with mild to moderate traumatic brain injury, 5 cases with mild to moderate traumatic brain injury and SUD, 1 cases with mild traumatic brain injury and alcohol use disorder within the last 12 months (AUD), and 2 cases with mild to moderate traumatic brain injury and AUD as well as SUD.
Abbreviation: HIV, human immunodeficiency virus.